Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brechtel

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Bacteriology|September 1, 1995
Pyridine carboxylic acids as inhibitors and substrates of the Escherichia coli gab permease encoded by gabPS C King, S R Fleming, C Brechtel
British Journal of Anaesthesia|August 23, 2005
Low dose of S+-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in vivoJ Benrath, C Brechtel, J Stark, et al.
Annals of Neurology|September 8, 2000
An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patientsK Kenney, C Brechtel, H Takahashi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Bacteriology|September 1, 1995
Pyridine carboxylic acids as inhibitors and substrates of the Escherichia coli gab permease encoded by gabPS C King, S R Fleming, C Brechtel
British Journal of Anaesthesia|August 23, 2005
Low dose of S+-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in vivoJ Benrath, C Brechtel, J Stark, et al.
Annals of Neurology|September 8, 2000
An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patientsK Kenney, C Brechtel, H Takahashi, et al.
Pageof 1